Literature DB >> 25802002

Actl6a protects embryonic stem cells from differentiating into primitive endoderm.

Weisi Lu1,2,3, Lekun Fang4, Bin Ouyang5, Xiya Zhang1,2, Shaoquan Zhan1,2, Xuyang Feng1,2, Yaofu Bai1,2, Xin Han1,2, Hyeung Kim3, Quanyuan He3, Ma Wan3, Feng-Tao Shi6, Xin-Hua Feng7, Dan Liu3, Junjiu Huang1,2, Zhou Songyang1,2.   

Abstract

Actl6a (actin-like protein 6A, also known as Baf53a or Arp4) is a subunit shared by multiple complexes including esBAF, INO80, and Tip60-p400, whose main components (Brg1, Ino80, and p400, respectively) are crucial for the maintenance of embryonic stem cells (ESCs). However, whether and how Actl6a functions in ESCs has not been investigated. ESCs originate from the epiblast (EPI) that is derived from the inner cell mass (ICM) in blastocysts, which also give rise to primitive endoderm (PrE). The molecular mechanisms for EPI/PrE specification remain unclear. In this study, we provide the first evidence that Actl6a can protect mouse ESCs (mESCs) from differentiating into PrE. While RNAi knockdown of Actl6a, which appeared highly expressed in mESCs and downregulated during differentiation, induced mESCs to differentiate towards the PrE lineage, ectopic expression of Actl6a was able to repress PrE differentiation. Our work also revealed that Actl6a could interact with Nanog and Sox2 and promote Nanog binding to pluripotency genes such as Oct4 and Sox2. Interestingly, cells depleted of p400, but not of Brg1 or Ino80, displayed similar PrE differentiation patterns. Mutant Actl6a with impaired ability to bind Tip60 and p400 failed to block PrE differentiation induced by Actl6a dysfunction. Finally, we showed that Actl6a could target to the promoters of key PrE regulators (e.g., Sall4 and Fgf4), repressing their expression and inhibiting PrE differentiation. Our findings uncover a novel function of Actl6a in mESCs, where it acts as a gatekeeper to prevent mESCs from entering into the PrE lineage through a Yin/Yang regulating pattern.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Actl6a; Embryonic stem cells; Primitive endoderm; Self-renewal; Tip60-p400 complex

Mesh:

Substances:

Year:  2015        PMID: 25802002     DOI: 10.1002/stem.2000

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  21 in total

Review 1.  Epigenetic Regulation by ATP-Dependent Chromatin-Remodeling Enzymes: SNF-ing Out Crosstalk.

Authors:  John S Runge; Jesse R Raab; Terry Magnuson
Journal:  Curr Top Dev Biol       Date:  2016-01-07       Impact factor: 4.897

2.  Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability.

Authors:  Ronit Marom; Mahim Jain; Lindsay C Burrage; I-Wen Song; Brett H Graham; Chester W Brown; Servi J C Stevens; Alexander P A Stegmann; Andrew T Gunter; Julie D Kaplan; Ralitza H Gavrilova; Marwan Shinawi; Jill A Rosenfeld; Yangjin Bae; Alyssa A Tran; Yuqing Chen; James T Lu; Richard A Gibbs; Christine Eng; Yaping Yang; Justine Rousseau; Bert B A de Vries; Philippe M Campeau; Brendan Lee
Journal:  Hum Mutat       Date:  2017-07-10       Impact factor: 4.878

3.  Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.

Authors:  Chiung-Ying Chang; Zohar Shipony; Sherry G Lin; Ann Kuo; Xiaochen Xiong; Kyle M Loh; William J Greenleaf; Gerald R Crabtree
Journal:  Mol Cell       Date:  2021-10-22       Impact factor: 17.970

4.  ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.

Authors:  Yang Xiao; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

5.  Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.

Authors:  Shuai Xiao; Rui-Min Chang; Ming-Yang Yang; Xiong Lei; Xiao Liu; Wen-Bin Gao; Jing-Lei Xiao; Lian-Yue Yang
Journal:  Hepatology       Date:  2016-01-26       Impact factor: 17.425

6.  BAF53a is a potential prognostic biomarker and promotes invasion and epithelial-mesenchymal transition of glioma cells.

Authors:  Li Meng; Xiaoyi Wang; Weihua Liao; Jianling Liu; Yiwei Liao; Qiongqiong He
Journal:  Oncol Rep       Date:  2017-10-10       Impact factor: 3.906

7.  Ddx56 maintains proliferation of mouse embryonic stem cells via ribosome assembly and interaction with the Oct4/Sox2 complex.

Authors:  Jingwen Wang; Jiahui Liu; Miaoman Ye; Feng Liu; Su Wu; Junjiu Huang; Guang Shi
Journal:  Stem Cell Res Ther       Date:  2020-07-23       Impact factor: 6.832

8.  ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.

Authors:  Zhijun Zeng; Hao Yang; Shuai Xiao
Journal:  BMC Cancer       Date:  2018-10-22       Impact factor: 4.430

9.  Differential expression of key subunits of SWI/SNF chromatin remodeling complexes in porcine embryos derived in vitro or in vivo.

Authors:  Birgit Cabot; Yu-Chun Tseng; Jennifer S Crodian; Ryan Cabot
Journal:  Mol Reprod Dev       Date:  2017-11-06       Impact factor: 2.609

10.  Baf53a is involved in survival of mouse ES cells, which can be compensated by Baf53b.

Authors:  Bo Zhu; Atsushi Ueda; Xiaohong Song; Shin-Ichi Horike; Takashi Yokota; Tadayuki Akagi
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.